首页> 外文OA文献 >PND37 PATIENT AND PHYSICIAN GLOBAL PERCEPTION OF LEVODOPA/ CARBIDOPA/ENTACAPONE VS. LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE EXPERIENCING EARLY WEARING-OFF

【2h】

PND37 PATIENT AND PHYSICIAN GLOBAL PERCEPTION OF LEVODOPA/ CARBIDOPA/ENTACAPONE VS. LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE EXPERIENCING EARLY WEARING-OFF

机译：PND37 LEVODOPA / CARBIDOPA / ENTACAPONE VS患者和医师的全球认知度。帕金森病的患者早期服用LEVODOPA / CARBIDOPA

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ruyra J; Balañá M; Lahoz R; Hernandez B; Tolosa E;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: A randomised, double-blind trial [J] . TolosaE., HernándezB., LinazasoroG., Journal of neural transmission . 2014,第4期

机译：左旋多巴/卡比多巴/ entacapone与左旋多巴/卡比多巴对早期帕金森氏病轻度衰老的疗效：一项随机，双盲试验
2. Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility-an open-label, 6-week study [J] . Karla Eggert, Orjan Skogar, Khaled Amar, Journal of neural transmission . 2010,第3期

机译：帕金森氏病伴衰老患者从左旋多巴/苄丝肼或左旋多巴/卡比多巴直接转换为左旋多巴/卡比多巴/他他酮：有效性，安全性和可行性-一项开放性的6周研究
3. Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study [J] . Karla Eggert, Örjan Skogar, Khaled Amar, Journal of Neural Transmission . 2010,第3期

机译：帕金森病伴衰老患者从左旋多巴/苄丝肼或左旋多巴/卡比多巴直接转换为左旋多巴/卡比多巴/他那卡酮：有效性，安全性和可行性—一项开放性的6周研究
4. Pharmacoscintigraphic evaluation in human of new floating minitablet formulationscontaining levodopa and carbidopa [C] . Goole J., Van Gansbeke B., Pilcer G., Annual meeting exposition of the Controlled Release Society . 2009

机译：含左旋多巴和卡比多巴的新型漂浮微型片剂对人体的药理学评价
5. Objective Vision-Based Assessment of Parkinsonism and Levodopa-Induced Dyskinesia in Persons with Parkinson's Disease. [D] . Li, Michael. 2017

机译：客观的基于视觉的帕金森氏病患者帕金森病和左旋多巴诱发的运动障碍评估。
6. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off [O] . Mikko Kuoppamäki, Mika Leinonen, Werner Poewe -1

机译：恩他卡朋在左旋多巴/卡比多巴与左旋多巴/苄丝肼治疗的帕金森氏病伴衰老患者中的疗效和安全性
7. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off [O] . Mikko Kuoppamäki, Mika Leinonen, Werner Poewe 2015

机译：恩他卡朋在左旋多巴/卡比多巴与左旋多巴/苄丝肼治疗的帕金森氏病伴衰老患者中的疗效和安全性

PND37 PATIENT AND PHYSICIAN GLOBAL PERCEPTION OF LEVODOPA/ CARBIDOPA/ENTACAPONE VS. LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE EXPERIENCING EARLY WEARING-OFF

著录项

引文网络

相似文献

相关主题

期刊订阅